{"organizations": [], "uuid": "39acda39d88b737708c50339598ca428d0a373a4", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.wsj.com", "main_image": "https://si.wsj.net/public/resources/images/BN-XJ811_TEVA02_SOC_20180208131603.jpg", "site_section": "https://www.wsj.com/news/cmo-today", "section_title": "CMO Today - Marketing and Media News - Wall Street Journal", "url": "https://www.wsj.com/articles/teva-pharmaceutical-shares-plunge-after-quarterly-loss-and-2018-outlook-warning-1518116066", "country": "US", "domain_rank": 387, "title": "Teva Pharmaceutical Shares Plunge After Quarterly Loss and 2018 Outlook Warning", "performance_score": 0, "site": "wsj.com", "participants_count": 1, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-02-08T21:54:00.000+02:00", "replies_count": 0, "uuid": "39acda39d88b737708c50339598ca428d0a373a4"}, "author": "Rory Jones", "url": "https://www.wsj.com/articles/teva-pharmaceutical-shares-plunge-after-quarterly-loss-and-2018-outlook-warning-1518116066", "ord_in_thread": 0, "title": "Teva Pharmaceutical Shares Plunge After Quarterly Loss and 2018 Outlook Warning", "locations": [], "entities": {"persons": [{"name": "kare schultz", "sentiment": "none"}], "locations": [{"name": "israel", "sentiment": "none"}, {"name": "u.s.", "sentiment": "none"}], "organizations": [{"name": "teva pharmaceutical industries ltd.", "sentiment": "negative"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Israel’s Teva Pharmaceutical Industries Ltd. on Thursday said it took a $17 billion charge against the value of its U.S. generics business and posted a $11.6 billion fourth-quarter loss, capping a tumultuous 2017 that saw a management and boardroom shake-up.\nWhile the world’s biggest generic drugmaker has struggled for months, the magnitude of the loss and a warning from Chief Executive Kare Schultz that 2018 could prove just as difficult sent the firm’s shares reeling.\n... ", "external_links": [], "published": "2018-02-08T21:54:00.000+02:00", "crawled": "2018-02-08T22:51:27.034+02:00", "highlightTitle": ""}